BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28581410)

  • 21. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.
    Hardcastle N; Hofman MS; Hicks RJ; Callahan J; Kron T; MacManus MP; Ball DL; Jackson P; Siva S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):196-204. PubMed ID: 26279034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer.
    Schmidt ML; Hoffmann L; Kandi M; Møller DS; Poulsen PR
    Acta Oncol; 2013 Oct; 52(7):1490-6. PubMed ID: 23905673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk.
    Hjelstuen MH; Mjaaland I; Vikström J; Dybvik KI
    Acta Oncol; 2012 Mar; 51(3):333-44. PubMed ID: 22171587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.
    Siva S; Devereux T; Ball DL; MacManus MP; Hardcastle N; Kron T; Bressel M; Foroudi F; Plumridge N; Steinfort D; Shaw M; Callahan J; Hicks RJ; Hofman MS
    Technol Cancer Res Treat; 2016 Feb; 15(1):114-21. PubMed ID: 25575575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome.
    Kataria T; Gupta D; Bisht SS; Karthikeyan N; Goyal S; Pushpan L; Abhishek A; Govardhan HB; Kumar V; Sharma K; Jain S; Basu T; Srivastava A
    Br J Radiol; 2014 Jun; 87(1038):20130643. PubMed ID: 24628269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of using motion compensated reconstructions for reducing inter-observer and intra-observer contouring variation for organs at risk in lung cancer patients.
    McWilliam A; Lee L; Harris M; Sheikh H; Pemberton L; Faivre-Finn C; van Herk M
    Radiother Oncol; 2018 Feb; 126(2):333-338. PubMed ID: 29221648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
    Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
    Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment.
    Kupelian PA; Ramsey C; Meeks SL; Willoughby TR; Forbes A; Wagner TH; Langen KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1024-8. PubMed ID: 16005575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
    Duffton A; Harrow S; Lamb C; McJury M
    Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
    Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
    Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of respiratory gating using 4-dimensional computed tomography on the dosimetry of tumor and normal tissues in patients with thoracic malignancies.
    Vlachaki M; Castellon I; Leite C; Perkins T; Ahmad S
    Am J Clin Oncol; 2009 Jun; 32(3):262-8. PubMed ID: 19433968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spect perfusion imaging versus CT for predicting radiation injury to normal lung in lung cancer patients.
    Weller A; Dunlop A; Oxer A; Gunapala R; Murray I; Gray MJ; Flux GD; deSouza NM; Ahmed M
    Br J Radiol; 2019 Sep; 92(1101):20190184. PubMed ID: 31287737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
    Petit SF; van Elmpt WJ; Oberije CJ; Vegt E; Dingemans AM; Lambin P; Dekker AL; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):698-705. PubMed ID: 20884128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.
    Fox J; Ford E; Redmond K; Zhou J; Wong J; Song DY
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):341-8. PubMed ID: 19038504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.